未登录

F

Fasiha Kanwal

baylor college of medicine

H指数:72

被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating a Polygenic Risk Score for Hepatocellular Carcinoma in Multiethnic Cirrhosis Patients in Texas

评估德克萨斯州多民族肝硬化患者中肝细胞癌的多基因风险评分

Cancer Medicine

IF3.1

2026-10-080

OAAI

Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study

乙型肝炎疫苗接种在美国肝移植受者中的应用：一项全国性队列研究

Clinical Infectious Diseases

IF7.3

2026-09-290

PRE

Inequalities in Developing Cirrhosis Complications Over Time: A Cohort Study

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2025-11-010

PRE

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort

HES V2.0的验证及性能与GALAD和ASAP在HEDS队列中的比较

Journal of Hepatology

IF33

2025-10-020

PRE

Menopause May Partially Explain Age-related Increased Risk of MASLD Fibrosis: A Causal Mediation Analysis

绝经可能部分解释与年龄相关的MASLD纤维化风险增加：一项因果中介分析

Clinical Gastroenterology and Hepatology

IF12

2025-09-270

PRE

Reflections on the Lancet Commission on Investing in Health's Global Health 2050 report

《柳叶刀》健康投资委员会《全球健康2050》报告的反思

IF0

2025-07-030

PRE

A Survey Study of Roadblocks in Translational Science

转化科学中的障碍调查研究

cts clinical and translational science

IF0

2025-06-270

OA

Risk of Hepatocellular Cancer in US Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus Interferon

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2025-02-070

PRE

Racial and ethnic disparities in extended criteria allograft use for liver transplantation

LIVER TRANSPLANTATION

IF3.9

2025-01-290

PRE

The impact of vitamin D supplementation on clinical outcomes in Inflammatory Bowel Disease: a regression discontinuity analysis

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-220

PRE

Older Age But Not Comorbidity Is Associated With Worse Survival in Patients With Hepatocellular Carcinoma

老年年龄而非合并症与肝细胞癌患者的较差生存率相关。

Clinical Gastroenterology and Hepatology

IF12

2024-11-200

PRE

Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis

HEPATOLOGY COMMUNICATIONS

IF4.6

2024-11-010

OAAI

National Liver Cancer Screening Trial (TRACER) study protocol

HEPATOLOGY COMMUNICATIONS

IF4.6

2024-11-012

OAAI

Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance

代谢功能障碍相关脂肪性肝病的Resmetirom治疗: AASLD实践指南的2024年10月更新

IF15.8

2024-10-180

OA

PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2024-09-015

PRE

Presentation of the AGA William Beaumont Prize in Gastroenterology to Hashem B. El-Serag, MD, MPH

GASTROENTEROLOGY

IF25.1

2024-08-010

PRE

HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States

IF15.8

2024-06-193

OAAI

Reply to: Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea

JOURNAL OF HEPATOLOGY

IF33

2024-05-010

PRE

Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2024-04-300

PRE

The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement

HEPATOLOGY COMMUNICATIONS

IF4.6

2024-02-0115

OAAI

Hagstrom, Hannes; Adams, Leon A.; Allen, Alina M.; Byrne, Christopher D.; Chang, Yoosoo; Duseja, Ajay; Gronbaek, Henning; Ismail, Mona H.; Jepsen, Peter; Kanwal, Fasiha; Kramer, Jennifer; Loomba, Rohit; Mark, Henry E.; Newsome, Philip N.; Rinella, Mary E.; Rowe, Ian A.; Ryu, Seungho; Sanyal, Arun; Schattenberg, Joern M.; Serper, Marina; Sheron, Nick; Simon, Tracey G.; Spearman, C. Wendy; Tapper, Elliot B.; Villota-Rivas, Marcela; Wild, Sarah H.; Wong, Vincent Wai-Sun; Yilmaz, Yusuf; Zelber-Sagi, Shira; Aberg, Fredrik; Lazarus, Jeffrey V.